2175 Genetic variants of UGT1A1 and 1A9 could be associated with Regorafenib induced toxicity in Japanese patients with metastatic colorectal cancer
Takeru Wakatsuki, Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Y. Fukunaga, Satoshi Nagayama(The Cancer Institute Hospital), Izuma Nakayama(National Cancer Center Hospital East), Yosuke Kumekawa, Daisuke Takahari(The Cancer Institute Hospital), Mariko Ogura(The Cancer Institute Hospital), Mitsukuni Suenaga, Yoshihiro Sato, Tomohiro Matsushima, Eiji Shinozaki(Japanese Foundation For Cancer Research), Keisho Chìn(The Cancer Institute Hospital), Takashi Ichimura, Masakatsu Ueno, Nobuyuki Mizunuma
Cited by 3
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|591
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|291